Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancers

Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancers

US Patent 11806374 · Granted Nov 7, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and system for calculating adaptive panel color parameters2025
Degradable regenerative medical material for promoting tissue in-situ regenerati2025
Therapeutic agents comprising nucleic acids and CAR-modified immune cells, and u2025
Therapeutic agents comprising nucleic acids and CAR-modified immune cells, and u2025
Single factor modeling-constraint method and device for mice chronic fatigue syn2025
Therapeutic agents comprising nucleic acids and TCR modified immune cells and us2023
Therapeutic agents comprising nucleic acids and TCR modified immune cells and us2023
Therapeutic compositions and applications that comprise nucleic acids and adopti2023
Therapeutic compositions and applications that comprise nucleic acids and adopti2023
Vehicle headlight2023
Simulation device for characterizing aerodynamics of dry power inhalants in resp2022
Therapeutic agents and uses thereof for drugs for treatment of tumors and/or can2022